M. Piccart-Gebhart - Concepedia

Author

M. Piccart-Gebhart

Also Known As

M J Piccart-Gebhart, M Piccart-Gebhart, M. Piccart-Gebhart, M.J. Piccart-Gebhart, MJ Piccart-Gebhart, Osborne, K.C.

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

M. Piccart-Gebhart is an author at German Breast group specializing in medicine, breast cancer, and oncology.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	225
2	Immunology	2	2	44
3	Health Sciences	1	1	11
4	Allergy	1	1	11
5	Cell Biology	1	1	33

M. Piccart-Gebhart

Publications

248

Citations

H-Index

Page 1

	Year	Citations
Abstract S3-3: First Results of the NeoALTTO Trial (BIG 01-06/EGF 106903): A Phase III, Randomized, Open Label, Neoadjuvant Study of Lapatinib, Trastuzumab, and Their Combination Plus Paclitaxel in Women with HER2-Positive Primary Breast Cancer José Baselga, Ian Bradbury, Holger Eidtmann, Cancer Research Lapatinib 1500Breast OncologyOncologyPhase IiiNeoaltto Trial	2010	116
Current management of advanced breast cancer. G. N. Hortobagyi, M. Piccart-Gebhart PubMed Surgical OncologyBreast OncologyMedicineCancer ManagementCurrent Management	1996	65
Abstract S1-05: Tumor infiltrating lymphocytes (TILs) indicate trastuzumab benefit in early-stage HER2-positive breast cancer (HER2+ BC) Sherene Loi, Stefan Michiels, Roberto Salgado, Cancer Research Breast OncologyImmunologyPathologyPharmacotherapyFinher Study	2013	33
S25 Update of the HERA trial and the role of 1 year Trastuzumab as adjuvant therapy for breast cancer L. Gianni, Aron Goldhirsch, R.D. Gelber, The Breast	2009	23
OT1-02-04: Adjuvant Pertuzumab and Herceptin IN IniTial TherapY of Breast Cancer: APHINITY (BIG 4–11/BO25126/TOC4939g). Minckwitz G von, José Baselga, I Bradbury, Cancer Research Breast OncologyImmunologyImmunotherapeuticsImmunotherapyHumanized Monoclonal Antibody	2011	11

Page 1